Antidepressants and REM sleep behavior disorder: Isolated side effect or neurodegenerative signal?

Sleep

Volumn 36, Issue 11, 2013, Pages 1579-1585

  Postuma, Ronald B ^a,b   Gagnon, Jean Francois ^b,c   Tuineaig, Maria ^b   Bertrand, Josie Anne ^b,d   Latreille, Veronique ^b,d   Desjardins, Catherine ^b   Montplaisir, Jacques Y ^b,d  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antidepressants; Parkinson disease; REM sleep behavior disorder

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; MIRTAZAPINE; PAROXETINE; PHENELZINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; COLOR VISION; CONSTIPATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEPRESSION; ERECTILE DYSFUNCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP DISORDER; SMELLING; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; UNIFIED PARKINSON DISEASE RATING SCALE;

ANTIDEPRESSANTS; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER;

AGED; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; COLOR PERCEPTION; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE, SECONDARY; PRODROMAL SYMPTOMS; PROSPECTIVE STUDIES; REM SLEEP BEHAVIOR DISORDER; RISK FACTORS; SMELL;

EID: 84887123703     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.3102     Document Type: Article

References (52)

1. Schenck CH, Mahowald MW REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in sleep. Sleep 2002; 25: 120-38. (Pubitemid 34193575)
2. Ohayon MM, Caulet M, Priest RG Violent behavior during sleep. J Clin Psychiatry 1997; 58: 369-76. (Pubitemid 27375470)
3. Schenck CH, Bundlie SR, Mahowald MW Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996; 46: 388-93.
4. Iranzo A, Molinuevo JL, Santamaria J, et al Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5: 572-7. (Pubitemid 43867426)
5. Postuma RB, Gagnon JF, Vendette M, Fantini M.L., Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009; 72: 1296-300.
6. Schenck CH, Boeve B, Mahowald MW Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16 year update on a previously reported series. Sleep Med 2013; 14: 744-8.
7. Postuma RB, Gagnon JF, Montplaisir J. Clinical prediction of Parkinson's disease - planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry 2010; 81: 1008-13.
8. Teman PT, Tippmann-Peikert M, Silber M.H., Slocumb NL, Auger RR Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med 2009; 10: 60-5.
9. Lam SP, Fong SY, Ho C.K., Yu MW, Wing YK Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatry 2008; 69: 1374-82.
10. Ju YE, Larson-Prior L, Duntley S. Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med 2011; 12: 278-83.
11. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004; 27: 317-21. (Pubitemid 44138844)
12. Gagnon JF, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology 2006; 67: 742-7. (Pubitemid 44394182)
13. Schenck CH, Mahowald MW, Kim S.W., O'Connor KA, Hurwitz TD Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992; 15: 226-35.
14. Lam SP, Zhang J, Tsoh J., et al REM sleep behavior disorder in psychiatric populations. J Clin Psychiatry 2010; 71: 1101-3.
15. Frauscher B, Gschliesser V, Brandauer E., et al REM sleep behavior disorder in 703 sleep-disorder patients: the importance of eliciting a comprehensive sleep history. Sleep Med 2010; 11: 167-71.
16. Lam SP, Li SX, Chan J.W., et al Does REM sleep behavior disorder exist in psychiatric populations? A clinical and polysomnographic case-control study. Sleep Med 2013; 14: 788-94.
17. Schenck CH, Hurwitz TD, Mahowald MW REM sleep behavior disorder. Am J Psychiatry 1988; 145: 652.
18. Alonso A, Rodriguez LA, Logroscino G, Hernan MA Use of antidepressants and the risk of Parkinson's disease: a prospective study. J Neurol Neurosurg Psychiatry 2009; 80: 671-4.
19. Weisskopf MG, Chen H, Schwarzschild M.A., Kawachi I., Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003; 18: 646-51. (Pubitemid 36790279)
20. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol 2011; 7: 323-31.
21. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006; 66: 845-51. (Pubitemid 43739758)
22. Postuma RB, Gagnon JF, Vendette M, Desjardins C., Montplaisir J. Olfaction and color vision identify impending neurodegeneration in REM behavior disorder. Ann Neurol 2011; 69: 811-8.
23. Postuma RB, Lang AE, Gagnon J.F., Pelletier A., Montplaisir JY How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012; 135: 1860-70.
24. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
25. Montplaisir J, Gagnon JF, Fantini M.L., et al Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 2010; 25: 2044-51.
26. Postuma RB, Gagnon JF, Vendette M, Montplaisir J. Markers of neurodegeneration in idiopathic REM sleep behavior disorder and Parkinson disease. Brain 2009; 132: 2298-307.
27. Gagnon JF, Vendette M, Postuma R.B., et al Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009; 66: 39-47.
28. Fahn S, Elton R, and members of the UDC. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, NJ: MacMillan HealthCare Information; 1987. p. 153-63.
29. Nutt JG, Lea ES, Van H.L., Schuff RA, Sexton GJ Determinants of tapping speed in normal control subjects and subjects with Parkinson's disease: differing effects of brief and continued practice. Mov Disord 2000; 15: 843-9.
30. Desrosiers J, Hebert R, Bravo G., Dutil E. The Purdue Pegboard Test: normative data for people aged 60 and over. Disabil Rehabil 1995; 17: 217-24.
31. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142-8.
32. Doty RL, Marcus A, Lee WW Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996; 106: 353-6.
33. Farnsworth D. The Farnsworth 100-hue test and dichotomous tests for color vision. J Optom Soc Am 1943; 33: 568-78.
34. Kinnear PR, Sahraie A. New Farnsworth-Munsell 100 hue test norms of normal observers for each year of age 5-22 and for age decades 30-70. Br J Ophthalmol 2002; 86: 1408-11. (Pubitemid 35408645)
35. Tison F, Seppi K, Sampaio C., et al Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004; 19: 1391-402. (Pubitemid 40104046)
36. Massicotte-Marquez J., Decary A, Postuma R.B., et al Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 2008; 70: 1250-7. (Pubitemid 351520966)
37. Postuma RB, Lang AE, Gagnon J.F., Pelletier A., Montplaisir JY How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012; 135: 1860-70.
38. Dubois B, Burn D, Goetz C., et al Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22: 2314-24. (Pubitemid 351155975)
39. McKeith IG, Dickson DW, Lowe J, et al Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-72. (Pubitemid 43970103)
40. Postuma RB, Aarsland D, Barone P., et al Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012; 27: 617-26.
41. Ross W, Petrovitch H, abbott R.D., et al Association of olfactory dysfunction with risk of future Parkinson's disease. Mov Disord 2005; 20(Supplement 10): S129-S30.
42. Berendse HW, Booij J, Francot C.M., et al Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 2001; 50: 34-41. (Pubitemid 32591460)
43. Siderowf A, Jennings D, Connolly J., Doty RL, Marek K, Stern MB Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease. Mov Disord 2007; 22: 2249-55.
44. Bertrand JA, Bedetti C, Postuma R.B., et al Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations. Mov Disord 2012; 27: 1781-8.
45. Savica R, Carlin JM, Grossardt B.R., et al Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology 2009; 73: 1752-8.
46. Abbott RD, Ross GW, Petrovitch H, et al Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007; 22: 1581-6. (Pubitemid 47477919)
47. Abbott RD, Petrovitch H, White L.R., et al Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57: 456-62. (Pubitemid 32757593)
48. Postuma RB, Gagnon JF, Vendette M, Montplaisir JY Idiopathic REM sleep behavior disorder in the transition to degenerative disease. Mov Disord 2009; 24: 2225-32.
49. Fahn S, Oakes D, Shoulson I., et al Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351: 2498-508.
50. Lam SP, Li SX, Mok V, Wing YK Young-onset REM sleep behavior disorder: Beyond the antidepressant effect. Sleep Med 2012; 13: 211.
51. Wing YK, Li SX, Mok V, et al Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83: 470-2.
52. Boot BP, Boeve BF, Roberts R.O., et al Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol 2012; 71: 49-56.